MENU
MNOV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Medicinova (MNOV) Ownership - Who owns Medicinova?

MediciNova Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
4275 Executive Square
Phone
+1 858 373-1500
Employees
13
Web
https://www.medicinova.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
62.91M
P/E Ratio
N/A
Total Cash
32.56M
Projected Growth
N/A
Total Debt
180.75K
Revenue
257.92K
Risk (Beta)
1.47
Dividend Yield
N/A
Total Cash/Share
0.66
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price

Fundamentals

MNOV
Capitalization
62.9M
P/E Ratio
N/A
Risk (Beta)
1.47
Dividend Yield
N/A
Total Cash
32.6M
Total Cash/Share
0.66
Total Debt
181K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
258K
ROE
N/A
Book Value
44M
P/B Ratio
1.43
Cash Flow
N/A
Earnings
-0.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
49K
Current Ratio
9.86
Current Revenue Per Employee
20553.17
Dividends Per Share - Security
N/A
EBITDA
-13.35M
Float
N/A
Float - Current
N/A
Gross Income Margin
6.53
Revenue To Assets
-22.73
Shares Held By Institutions
8.11M
Shares Outstanding - Current
49.1M
Total Liabilities
3.61M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-39.048
View a ticker or compare two or three
MNOV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MNOV showed earnings on November 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which develops small molecule therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4275 Executive Square
Phone
+1 858 373-1500
Employees
13
Web
https://www.medicinova.com